PDGFRB-rearranged cases preferentially manifest as chronic myelomonocytic leukemia (CMML), and less frequently as CEL, MPN or atypical chronic myeloid leukemia (aCML) [1,3,29,30]. This evidence concerns the gene PDGFRB and atypical chronic myeloid leukemia, BCR-ABL1 negative.